GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,277 | +62.4% | 211,789 | +84.2% | 0.00% | +100.0% |
| Q2 2023 | $224,248 | +250.4% | 114,999 | +644.9% | 0.00% | – |
| Q1 2022 | $64,000 | -54.6% | 15,439 | +40.5% | 0.00% | -100.0% |
| Q4 2021 | $141,000 | -86.0% | 10,987 | -88.2% | 0.00% | -80.0% |
| Q3 2021 | $1,007,000 | -11.8% | 93,202 | -25.5% | 0.01% | -16.7% |
| Q2 2021 | $1,142,000 | +1042.0% | 125,084 | +1082.3% | 0.01% | +500.0% |
| Q1 2021 | $100,000 | +1566.7% | 10,580 | +624.2% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 1,461 | +303.6% | 0.00% | – |
| Q3 2020 | $1,000 | -85.7% | 362 | -42.4% | 0.00% | – |
| Q2 2019 | $7,000 | – | 628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |